Ionis Pharmaceuticals IONS Revenue
Revenue at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's revenue?
- Ionis Pharmaceuticals (IONS) reported revenue of $246.09M in Q1 2026.
- How has Ionis Pharmaceuticals's revenue changed year-over-year?
- Ionis Pharmaceuticals's revenue increased by 87.0% year-over-year, from $131.61M to $246.09M.
- What is the long-term trend for Ionis Pharmaceuticals's revenue?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's revenue has grown at a 3.9% compound annual growth rate (CAGR), from $810.46M to $943.71M.
- What does revenue mean?
- Total revenue earned from core business contracts with customers.
- How do you interpret revenue?
- An increase indicates successful commercialization or milestone achievement, while a decrease suggests lower demand or fewer contract completions.
- How does revenue compare across companies?
- Standard top-line revenue metric reported by all public companies under GAAP or IFRS.